BGAI
JAZZ icon

Bruce G. Allen Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bruce G. Allen Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13
Closed -$1.61K – 1112
2025
Q1 		$1.61K Hold
13
– – ﹤0.01% 738
2024
Q4 		$1.6K Hold
13
– – ﹤0.01% 751
2024
Q3 		$1.45K Hold
13
– – ﹤0.01% 766
2024
Q2 		$1.39K Buy
13
+10
+333% +$1.1K ﹤0.01% 733
2024
Q1 		$361 Sell
3
-14
-82% -$1.72K ﹤0.01% 882
2023
Q4 		$2.09K Buy
+17
New +$2.12K ﹤0.01% 729

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bruce G. Allen Investments's JAZZ Position: Q2 2025 in Review

Bruce G. Allen Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 13 shares — an estimated $1.61K sold.

Bruce G. Allen Investments first reported a position in JAZZ in Q4 2023 and held it in 6 quarters. The position peaked at $2.09K in Q4 2023. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Bruce G. Allen Investments reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Bruce G. Allen Investments sold 13 Jazz Pharmaceuticals shares in Q2 2025, an estimated $1.61K.
  • Bruce G. Allen Investments first reported a position in Jazz Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Bruce G. Allen Investments's Jazz Pharmaceuticals position peaked at $2.09K in Q4 2023.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Bruce G. Allen Investments's 13F filing for Q2 2025, filed 9 Jul 2025.